Application of big data technology for COVID-19: Health economics of COVID

K. Hauck (London, United Kingdom)

Source: ERS Course 2021 - COVID-19: State of the art
Number: 31

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Hauck (London, United Kingdom). Application of big data technology for COVID-19: Health economics of COVID. ERS Course 2021 - COVID-19: State of the art

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Application of big data technology for COVID-19: Primary care big data
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Health economics of diagnostics
Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course
Year: 2019

Application of big data technology for COVID-19: Panel discussion
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

An homogenous European approach for SBD management, incorporating new technologies and the Sleep Revolution project
Source: Virtual Congress 2021 – Sleep and breathing disorders
Year: 2021


Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives
Source: Eur Respir J, 50 (5) 1701632; 10.1183/13993003.01632-2017
Year: 2017



Big data analysis in telemedicine in sleep: the European status, opportunities and pitfalls
Source: Virtual Congress 2021 – Digital health meets sleep breathing disorders
Year: 2021


Health Research collaboration in Europe: an innovative initiative
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013


Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best practices and different approaches to communication with pharmaceutical companies
Source: International Congress 2016 – PD5 Establishing core facilities for measuring clinical trial outcomes 
Year: 2016

The future of health care. The perspective of the UK Health Policy Makers
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011


eTRIKS IT platfroms for large-scale biomedical research
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Promoting respiratory public health through epigenetics research: an ERS Environment Health Committee workshop report
Source: Eur Respir J, 51 (4) 1702410; 10.1183/13993003.02410-2017
Year: 2018



The Interministerial Conference on Environment and Health in Budapest: outcome and perspectives for action and research in respiratory health
Source: Annual Congress 2004 - European and other initiatives in the field of respiratory health and the environment
Year: 2004

Digital health technology for the end TB strategy: Developing priority products and making them work
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


Productivity loss in COPD: Results from the BOLD study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Research in Europe: from basic science to interdisciplinary approach
Source: Annual Congress 2013 –President Summit 2013 update: Research gaps, patient needs & innovative solutions: a forward look on lung health research
Year: 2013


Analysis of tobacco control in Turkey through political mapping
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016


Research emphysis in China: big data network for respiratory health
Source: International Congress 2019 – Chinese programme 2019: Part I
Year: 2019